207 related articles for article (PubMed ID: 25476151)
1. Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer.
Li J; Liu J; Ren Y; Liu P
Exp Biol Med (Maywood); 2015 Mar; 240(3):324-8. PubMed ID: 25476151
[TBL] [Abstract][Full Text] [Related]
2. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.
Guler G; Huebner K; Himmetoglu C; Jimenez RE; Costinean S; Volinia S; Pilarski RT; Hayran M; Shapiro CL
Cancer; 2009 Feb; 115(4):899-908. PubMed ID: 19130459
[TBL] [Abstract][Full Text] [Related]
3. The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding.
Ferguson BW; Gao X; Zelazowski MJ; Lee J; Jeter CR; Abba MC; Aldaz CM
BMC Cancer; 2013 Dec; 13():593. PubMed ID: 24330518
[TBL] [Abstract][Full Text] [Related]
4. WWOX: a fragile tumor suppressor.
Schrock MS; Huebner K
Exp Biol Med (Maywood); 2015 Mar; 240(3):296-304. PubMed ID: 25538133
[TBL] [Abstract][Full Text] [Related]
5. Wwox inactivation enhances mammary tumorigenesis.
Abdeen SK; Salah Z; Maly B; Smith Y; Tufail R; Abu-Odeh M; Zanesi N; Croce CM; Nawaz Z; Aqeilan RI
Oncogene; 2011 Sep; 30(36):3900-6. PubMed ID: 21499303
[TBL] [Abstract][Full Text] [Related]
6. Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer.
Abdeen SK; Ben-David U; Shweiki A; Maly B; Aqeilan RI
Cell Death Dis; 2018 Aug; 9(8):832. PubMed ID: 30082886
[TBL] [Abstract][Full Text] [Related]
7. WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.
Aldaz CM; Ferguson BW; Abba MC
Biochim Biophys Acta; 2014 Aug; 1846(1):188-200. PubMed ID: 24932569
[TBL] [Abstract][Full Text] [Related]
8. Characterization of WWOX inactivation in murine mammary gland development.
Abdeen SK; Salah Z; Khawaled S; Aqeilan RI
J Cell Physiol; 2013 Jul; 228(7):1391-6. PubMed ID: 23254778
[TBL] [Abstract][Full Text] [Related]
9. WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer.
Chen S; Wang H; Huang YF; Li ML; Cheng JH; Hu P; Lu CH; Zhang Y; Liu N; Tzeng CM; Zhang ZM
Mol Cancer; 2017 Jul; 16(1):128. PubMed ID: 28724435
[TBL] [Abstract][Full Text] [Related]
10. Wwox and Ap2gamma expression levels predict tamoxifen response.
Guler G; Iliopoulos D; Guler N; Himmetoglu C; Hayran M; Huebner K
Clin Cancer Res; 2007 Oct; 13(20):6115-21. PubMed ID: 17947476
[TBL] [Abstract][Full Text] [Related]
11. WWOX, a new potential tumor suppressor gene.
Hezova R; Ehrmann J; Kolar Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):11-5. PubMed ID: 17690733
[TBL] [Abstract][Full Text] [Related]
12. Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations.
Maeda N; Semba S; Nakayama S; Yanagihara K; Yokozaki H
Virchows Arch; 2010 Oct; 457(4):423-32. PubMed ID: 20737170
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features.
Guler G; Himmetoglu C; Jimenez RE; Geyer SM; Wang WP; Costinean S; Pilarski RT; Morrison C; Suren D; Liu J; Chen J; Kamal J; Shapiro CL; Huebner K
Breast Cancer Res Treat; 2011 Sep; 129(2):421-32. PubMed ID: 21069451
[TBL] [Abstract][Full Text] [Related]
14. The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism.
Aqeilan RI; Hassan MQ; de Bruin A; Hagan JP; Volinia S; Palumbo T; Hussain S; Lee SH; Gaur T; Stein GS; Lian JB; Croce CM
J Biol Chem; 2008 Aug; 283(31):21629-39. PubMed ID: 18487609
[TBL] [Abstract][Full Text] [Related]
15. Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase.
Chang Y; Lan YY; Hsiao JR; Chang NS
Exp Biol Med (Maywood); 2015 Mar; 240(3):329-37. PubMed ID: 25488911
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype.
Wang X; Chao L; Ma G; Chen L; Zang Y; Sun J
J Cancer Res Clin Oncol; 2011 Feb; 137(2):271-8. PubMed ID: 20401669
[TBL] [Abstract][Full Text] [Related]
17. WWOX: its genomics, partners, and functions.
Del Mare S; Salah Z; Aqeilan RI
J Cell Biochem; 2009 Nov; 108(4):737-45. PubMed ID: 19708029
[TBL] [Abstract][Full Text] [Related]
18. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of ubiquitin-conjugating enzyme E2C, leucine-rich repeated-containing G protein-coupled receptor, WW domain-containing oxidoreductase, and vasculogenic mimicry in invasive breast carcinoma.
Shen R; Wu T; Huang P; Shao Q; Chen M
Medicine (Baltimore); 2019 Apr; 98(16):e15232. PubMed ID: 31008954
[TBL] [Abstract][Full Text] [Related]
20. VOPP1 promotes breast tumorigenesis by interacting with the tumor suppressor WWOX.
Bonin F; Taouis K; Azorin P; Petitalot A; Tariq Z; Nola S; Bouteille N; Tury S; Vacher S; Bièche I; Rais KA; Pierron G; Fuhrmann L; Vincent-Salomon A; Formstecher E; Camonis J; Lidereau R; Lallemand F; Driouch K
BMC Biol; 2018 Oct; 16(1):109. PubMed ID: 30285739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
